Navigation Links
Roche Diabetes Care in the U.S. Turns to Social Media to Promote Diabetes Education, Awareness and Advocacy
Date:4/6/2011

INDIANAPOLIS, April 6, 2011 /PRNewswire/ -- Roche Diabetes Care, makers of ACCU-CHEK® products and services, has launched dedicated Facebook and Twitter accounts to promote diabetes education, awareness and advocacy. The company has also expanded its current Diabetes Link blog from Canada to North America.

Roche Diabetes Care's Facebook (www.facebook.com/AccuChekUS) and Twitter (www.twitter.com/accuchek_us) accounts have been created with one goal in mind: help people with diabetes, as well as the friends and families who support them, learn more about how to live healthy lives while successfully managing their diabetes. Roche chose the ACCU-CHEK name for its Facebook and Twitter accounts to help its diabetes customers – most of whom know the company's products only by their brand names – more easily find these new social media tools.

The company also reworked its highly successful blog, Diabetes Link (www.accu-chekdiabeteslink.com), to benefit audiences in both Canada and the United States. Diabetes Link was launched in October 2009.

"Living with diabetes is hard, and the many misconceptions, assumptions and half-truths out there don't make it any easier," said Todd Siesky, public relations and social media manager for Roche Diabetes Care in the United States. "There are a great number of diabetes advocates online who are already doing an outstanding job of education and advocacy work on behalf of people living with diabetes. We hope to amplify their voices as well as highlight issues important to everyone in the diabetes online community."

A partial list of some of the most influential diabetes online writers can be found at Diabetes Link (www.accu-chekdiabeteslink.com) under the headline "What We're Reading." Roche has been working with many of these writers for the past two years to better understand how it can support online education, advocacy and awareness issues important to them.

In addition to following @accuchek_us on Twitter and liking Roche's diabetes Facebook page at AccuChekUS, people interested in diabetes are also encouraged to sign up for the latest postings from the Diabetes Link at www.accu-chekdiabeteslink.com.

About Roche Diabetes Care

Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, Roche has been committed to helping people with diabetes live lives that are as normal and active as possible and has been helping healthcare professionals manage their patients' condition in an optimal way. Today, the ACCU-CHEK portfolio offers people with diabetes and healthcare professionals innovative products, services and comprehensive solutions for convenient, efficient and effective diabetes management—from blood glucose monitoring through information management to insulin delivery. The ACCU-CHEK brand encompasses blood glucose meters, infusion pumps, lancing and data management systems. For more information, please visit accu-chek.com.

About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2010, Roche had over 80,000 employees worldwide and invested over 9 billion Swiss francs in R&D. The Group posted sales of 47.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.

All trademarks used or mentioned in this release are protected by law.

For further information, please contact:

Todd Siesky
Public Relations Manager
Roche Diabetes Care
Indianapolis, IN
(317) 521-3966 O
(317) 361-7637 C
todd.siesky@roche.com


'/>"/>
SOURCE Roche Diabetes Care
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Pivotal Study Validates Roches cobas® HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical Cancer
2. Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial With Subcutaneous MabThera® (rituximab)
3. Roche, Baylor Research Institute Partner in Human Immunology Research
4. Roche Diabetes Care Forms Human Blue Circle, Supports Viral Video for World Diabetes Day
5. Heiner Dreismann, Ph.D., Former President of Roche Molecular Systems, Joins the HistoRx Board of Directors
6. InterMune Sells Danoprevir Rights to Roche for $175 Million
7. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
8. Sanford Rose Associates(R)-Rochester Named Top Office
9. Pfizer, Merck, Roche/Genentech, GSK, J&J, BMS and More to Speak at Contracting & Outsourcing 2010
10. Roche Diabetes Care and ICW Announce Technology Partnership
11. International Society for Cellular Therapy (ISCT) joins forces with Roche and Genzyme to launch Cell Therapy Industry Partnership.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., ... a Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. ... best practices and how Proscia improves lab economics and realizes an increase in ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... , Oct. 10, 2017 International research firm Parks Associates ... will speak at the TMA 2017 Annual Meeting , October 11 ... in the residential home security market and how smart safety and security ... Parks Associates: ... "The residential security ...
(Date:10/9/2017)... ... ... The award-winning American Farmer television series will feature 3 Bar Biologics in an ... on RFD-TV. , With global population estimates nearing ten billion people by 2050, ... a growing nation. At the same time, many of our valuable resources are becoming ...
Breaking Biology Technology:
(Date:4/13/2017)... April 13, 2017 UBM,s Advanced Design and ... will feature emerging and evolving technology through its 3D ... will run alongside the expo portion of the event ... and demonstrations focused on trending topics within 3D printing ... and manufacturing event will take place June 13-15, 2017 at ...
(Date:4/11/2017)... April 11, 2017 Crossmatch®, a globally-recognized ... solutions, today announced that it has been awarded ... Projects Activity (IARPA) to develop next-generation Presentation Attack ... "Innovation has been a driving force within ... will allow us to innovate and develop new ...
(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
Breaking Biology News(10 mins):